Robert E. Funck Jr.
Net Worth

Last updated:

What is Robert E. Funck Jr. net worth?

The estimated net worth of Mr. Robert E. Funck Jr. is at least $60,967,330 as of 10 May 2024. He owns shares worth $27,793,455 as insider, has earned $6,443,875 from insider trading and has received compensation worth at least $26,730,000 in Abbott Laboratories.

What is the salary of Robert E. Funck Jr.?

Mr. Robert E. Funck Jr. salary is $2,430,000 per year as Executive Vice President of Fin. & Chief Financial Officer in Abbott Laboratories.

How old is Robert E. Funck Jr.?

Mr. Robert E. Funck Jr. is 64 years old, born in 1961.

What stocks does Robert E. Funck Jr. currently own?

As insider, Mr. Robert E. Funck Jr. owns shares in one company:

Company Title Shares Price per share Total value
Abbott Laboratories (ABT) Executive Vice President of Fin. & Chief Financial Officer 211,341 $131.51 $27,793,455

What does Abbott Laboratories do?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Robert E. Funck Jr. insider trading

Abbott Laboratories

Mr. Robert E. Funck Jr. has made 11 insider trades between 2014-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 83,333 units of ABT stock on 26 Oct 2020. As of 10 May 2024 he still owns at least 211,341 units of ABT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Option (right to buy) 10,097 $47 $474,559
Sale
Common shares without par value 10,097 $104.57 $1,055,823
Option
Common shares without par value 10,097 $47 $474,559
Sale
Common shares without par value 1,264 $100.7 $127,285
Option
Option (right to buy) 31,325 $39.12 $1,225,434
Option
Common shares without par value 31,325 $39.12 $1,225,434
Sale
Common shares without par value 83,333 $38.4 $3,199,987
Option
Option (right to buy) 83,333 $38.4 $3,199,987
Option
Common shares without par value 83,333 $38.4 $3,199,987
Option
Option (right to buy) 36,700 $37.03 $1,359,001
Option
Common shares without par value 36,700 $37.03 $1,359,001
Sale
Common shares without par value 1,356 $77.89 $105,619
Option
Common shares without par value 40,000 $34.94 $1,397,600
Option
Option (right to buy) 40,000 $34.94 $1,397,600
Sale
Common shares without par value 1,002 $78 $78,156
Option
Option (right to buy) 9,700 $26.19 $254,024
Option
Common shares without par value 36,400 $25.2 $917,426
Option
Common shares without par value 12,800 $26.02 $332,992
Option
Option (right to buy) 12,800 $26.02 $332,992
Sale
Common shares without par value 1,220 $58.99 $71,970
Option
Common shares without par value 25,500 $26.7 $680,774
Option
Option (right to buy) 25,500 $26.7 $680,774
Sale
Common shares without par value 25,500 $26.7 $680,774
Option
Option (right to buy) 26,800 $25.25 $676,593
Option
Common shares without par value 26,800 $25.25 $676,593
Sale
Common shares without par value 26,800 $25.25 $676,593
Sale
Common shares without par value 1,333 $39.3 $52,392
Option
Common shares without par value 26,000 $21.22 $551,694
Option
Option (right to buy) 26,000 $21.22 $551,694
Option
Common shares without par value 10,542 $22.27 $234,739
Option
Option (right to buy) 10,542 $22.27 $234,739
Sale
Common shares without par value 1,413 $38.97 $55,069
Option
Common shares without par value 9,398 $33.52 $315,049
Sale
Common shares without par value 9,398 $36.2 $340,208
Option
Option (right to buy) 2,137 $31.61 $67,546

Abbott Laboratories key executives

Abbott Laboratories executives and other stock owners filed with the SEC: